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NOTE OF

EXPLfu~ATION

This thesis is written in a fo rm acceptible for publication in

Analytical Toxicology and will be submitted to the journal Oct ober,
1979.
sulfite

A general review of literature on cysteine- S- sulfonate and
~~posure

has been included in the appendix.
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AllSTRACT
A Rapid and Specific Ga s Chromatographic Analysis f or
Cysteine- S- sul fonate to Determine t he Distribution
of Sulfite in Mammalian Plasma
by
Joseph Don deBethizy, Master of Science
Utah State Universit y, 1979
Major Professor:
Dr. Josep h C. S tr eet
Department:
Animal, Dair y , Veter inar y Sciences

(Toxicology )
It has be en shown in previous studies that when sulfite is ab-

sorbed by rabbits v ia either inhalation of

so 2

or oral

~~posure

to

sulfit e, the hydrated form , bi sulf ite , interacts with plasma disulfides
where it is s uspected to be in the form, cys t eine- S-sulfo na te.

A rapid

and specific gas chromatographic anal ys is proc edure for cysteine- S-

sulfona t e has been developed to better stud y the distribution of sulfi t e in biological systems.

Sulfona t ed proteins are enzymaticall y

hydrol yzed to ensure stability of t he acid labile S-sulfonate disul fide.

The hydrol ysate is then app li ed to a 6 em cat ion- exchange

column and eluted wit h 0.1 N HCl which elutes the ac i dic cysteine- Ssulfonate with the void vol ume of the column leaving be hind a ny remaining cysteine .

The silylated derivativ es of the column effluent

are prepared using Tri- Sil/BSA.

These derivatives are injected into a

gas chromatograph equipped wi t h a flame-photometric detecto r operating
in the sulfur mode, 2% OV-101 on Chromosorb W/ HP 1/4 inch glas s column,
oven temperature 140°C, and carrier flow rate of 86 ml/min.

The

presen ce of cysteine-S- sulfonate in sulfite treated rabb i ts bas been

d irectl y determined by the described method.
(4 5 pages )

INTRODUCTION

~~n

is exposed to sulfite principally through the inhalation of

the gaseous pollutant, 50 2 , and by ingestion of sulfite used in the
processing of food and beverages (1).

Regardle ss of the route of

exposure, 50 2 /sulfite is rapidly absorbed into the circulatory system
of mammals as bisulfi te (2).

However, the distribution of bisulfite

among blood constituents and the molecular forms in which it is bound

in mammals have not been completely elucidated.

Yokoyama, et al (3)

followed the distribution of radio- labeled sulfur after treating nine
dogs to 22 and 50 ppm

35

50 2 .

These investigators ascertained the

rate at which 355 entered the circulation from the mucosa of the upper
airways, the extent of deposition in peripheral tissues and the rate
at which it was excreted from the dogs, but

~vere

unable to determine

the molecular forms of the bound 355 .
Gunnison and Benton (4) suggested that cystine and other physiclogical disulfides may act as the primary sinks for bisulfite in
mammalian plasma by the following reaction:

R55R + H50j

R550J + R5H
pH 7.4

This reaction, known as sulfitolysis, has been used as a gentle method

for breaking disulfides in structural investigations of proteins (5).
Confirmation of the formation of cysteinyl-5- sulfonate residues in
sulfonated proteins has only been indirectly demonstrated because of
the relative lability of the S- sulfonate moiety to conventional acid
hydrolysis of proteins.

Gunnison and Benton circumvented this problem

by developing a colorimetric method for following the uptake of inor -

ganic sulfite by disulfides and the subsequent displacement of the
bound sulfite with alkaline cyanide.

Adapting this indirect method to

physiological samples, Gunnison was able to implicate the involvement
of cysteine-S-sulfonate as the major sink for bisulfite in mammalian

plasma (6,7 , 8).

However, the Gunnison method lacks specificity for

cysteine-S-s~lfonate

and is subject ta

inte~fering

plasma constituents

which limit the sensitivity of the colorimetric assay (4).
The purpose of the present investigation was to develop a rapid
and specific gas chromatographic determination for cysteine-S-sulfonate

in proteins using enzymatic hydrolysis and the specificity of the
flame-photometric detector operated in the sulfur mode.

Reports of

the use of GLC for separation and detection of S-containing amino

acids, however, are limited.

Ca~dwell

and Tappel (9) separated the

silylated derivatives of a variety of sulfa-and selena-amino acids and

their oxidation products by GLC.

In a more thorough study of the gas

chromatography of sulfur amino acids, Shahrokhi and Gehrke (10)
quantitatively prepared the TMS derivatives of twelve sulfur-containing
amino acids.

Separation and detection was achieved using a 0.5% w/w

OV-1 column and a flame ionization detector.

confirmed by elemental analysis.

The TMS derivatives were

Neither group attempted the deriva-

tization of cysteine-S-sulfonate.

Earlier methods for direct determination of free S-sulfonates did
not lend themselves to routine evaluation of physiological samples.
DeMarco, et al (11) demonstrated the chromatographic behavior of
cysteine- S- sulfonate on the long cation-exchange column of a Model 120
Beckman-Spinco Amino Acid Analyzer.

They were able to show elution of

3

the acidic S-sulfonate and cysteic acid within the void volume of the

column.

Ruffin and Biserte (12) achieved separation of cysteine- S-

sulfonate and cysteic acid by using an 0.8 em x 35 em anion exchange
column fitted to a Multichrom Amino Ac id Analyzer.

Sensitivity of

these methods was limited by the ninhydrin detection system .
To chromatographically determine cysteine- S-sulfonate residues in
sulfonated proteins, the proteins must be quantitatively hydrolyzed.
Enzymatic hydrolysis was the method of choice to prevent hydrolysis of
the acid-labile S- sulfonate disulfide.

Complete enzymatic hydrolysis

of proteins was demonstrated by Hill and Schmidt (13).

They used a

battery of three enzymes; papain, leucine amino peptidase, and prolidase to achieve "close to theoretical amounts" of amino acids

ordinarily qu it e labile during acid hydrolysis of proteins.

These

investigators pointed out that cysteine was the most resistant amino
acid to enzymatic hydrolysis.

The use of pronase for enzymatic protein

digestion has been promoted as a relatively non- specific endopeptidase

producing a mixture of short peptides and free amino acids (14, 15).
It was hoped that pronase would be mo re active than papain on the more
resistant cysteine residues .
~Vi th

these considerations, we have employed a method utilizing

enzymatic hydrolysis, ion-exchange column chromatography, and GLC to
directly determine cysteine- S-sulfonate in sulfonated proteins.

4

MATERIALS AND METHODS

Materials

Crystalized and lyophilized bovine serum albumin; L-cysteic acid;
prolidase from pig kidney (highly purified suspension in 2. 7M (NH 4 )so4
solution, pH 8); leucine amino peptidase from hog kidney, Type III-CP;
and protease from Streptomyces griseus (Pronase), repurified Type VI,

were obtained from Sigma Chemical Co.

Anhydrous sodium sulfite,

sodium metabisulfite, and dichloromethane (nanograde solvent) were

obtained from Mallinckrodt Chemical Works.

N,O-bis(Trimethylsilyl)-

acetamide in silylation grade dimethyl formamide (Tri-Sil BSA) was
obtained in 1.0 ml ampules from Pierce Chemical Co.

Sodium tetra-

thionate was synthesized by the method of Gilman, et al, (16).

Sodium

cysteine-S-sulfonate monohydrate was synthesized by the method of
Segel and Johnson (17).

Sulfonated bovine serum albumin (S-BSA) was

prepared by the method of Bailey and Cole (5).

Enzymatic Hydrolysis
All proteolytic enzymes were used as commercially supplied except

for the removal of exogenous amino acids by dialysis against three
changes of 200 volumes of buffer (SmM Tris, pH 8.0, SmM MgClz) for
four hours (MgClz excluded for Pronase).

The method for enzymatic

hydrolysis was an adaptation of the method by Hill and Schmidt (13).
Sulfonated-bovine serum albumin (S- BSA), 20 mg, was dissolved in 4.0
ml of glass distilled water and adjusted to pH 5.0 with lN NaOH.

Sufficient stock Tris, pH 8.0, was added to produce a final concentra-

tion of 5mM Tris.

The buffered protein solution was equilibrated to

39°C in a shaking water bath.

The first stage of hydrolysis was

started by adding 1 . 0 ml Pronase solution (2 mg Pronase/1.0 m1 5mM
Tris, pH 8.0) to the protein solution.

After 12 hours of digestion,

the pronase was inactivated by bringing the digest to pH 2. 0 1dth lN
HCl.

After 20 minutes, the digest was returned to pH 8.0 with lN

NaOH and made

5nu~

in MgC1 2 .

The second stage of hydrolysis was started with the addition of
0.5 ml LAP (2mg/ml) and 0.2 ml of prolidase (10 mg/ml) to the digest.
After 12 hours of incubation the digest was adjusted to pH 2.0 with
1.0 M HCl for 20 minutes .

Any protein that precipitated at this point

was sedimented and the supernatent lyophilized.

The lyophilized

samples were stored dessicated and frozen until needed.

The progress

o f the enzymatic hydrolysis was monitored spectrophotometrically with

ninhydrin at 570 nm, (18).

Short Cation-Exchange Column Chromatography
(Column Preparation) Dowex 50-X4, 100-200 mesh (Eio Rad) was used
in preparing a 5. 8 em x 1.8 em column.

The resin was equilibrated with

several washes of the eluant, 0.1 N HCl.
(Elution) Samples, dissolved in 1.0 ml of eluant, were placed on
the column and rinsed into the column with 1.0 ml of the eluant.

The

cysteine-5-sulfonate was eluted with a continuous flow of 0.1 N HCl.
During method development, successive 1.0 ml fractions were collected
to insure quantitative recovery of the sulfonated amino acid.

An

appropriate aliquot of each fraction was transferred to the silylation
reaction vial fo r derivatization .

For routine analyses, the cysteine-

S-sulfonate was recovered by batch elution.

Silylation
Prior to gas chromatography, samples were silylated •Nith commercially prepared Tri- Sil/BSA .

Aqueous samples were transferred to

silylat i on react ion vial s and taken to dryness under a

Nz

stream.

The

sample s (l.Oumole amino acid/100 ul Tri-Sil) were silyla ted fo r 15
minutes at 100±2 °C in a constant temperature oil bath .

It was impor -

tant to submerge t he reaction vial s in the oil to the level of the
sample to allow adequate refluxing.

After 15 minutes the reaction

vial was rapidly cooled and 5 ul injected onto the GLC column .

Screw-

cap vials* with teflon septa were used so that aliquots could be
removed by syringe.

Cysteine required dilution with dicllloromethane

(1:10 v/v) prior to injection on the column.

GLC Appar a tu s
Samples were chromatographed in a Tracor (Traco r , Inc.) MT 220
gas chromatogra ph equipped with a Melpar , Inc. flame photometric
detecto r operable to 165°C.

A narrow band optical filter with max-

imum transmission at 394 nm and a half -wid th of 5 nm was used wi th the
detecto r .

Nitrogen served as the carrier gas while the detector was

serviced by hydrogen , oxygen , and air .

All gas cylinders wer e equi pped

*Reactivials, 2 ml, Pierce Chemica l Company

with Tracer filter - driers to remove trace hydrocarbons and water .

A

two pen, 1 mv Micro-tek recorder monitored both FID and FPD responses.

A 6.4 x l0- 9 amp signal produced a full - scale deflection at maximum
input and output settings on the two-channel electrometer.

A 1.8 m

x 4 mm i.d. boro - silicate glass column containing 2.0% (w/w) OV- 101
on 80/100 mesh Chromosorb W- HP was used for separation and quantitation
of the S-amino acids.

The column was prepared and conditioned by the

method of Leibrand, et al (17).

Method Application, in vivo

One male , New Zealand White rabbit, 4 kg, was treated with 0.7
mmole sulfite / kg body weight by intravenous injection in the marginal
ear vein.

The sulfite solution was prepared by dissolving sodium

metabisulfite in normal saline and adjusting t o pH 7.4 with NaOH.
Total injection volume was 1 . 34 ml and was administered at a rate of

approximately l ml/min.

Whole blood was collected (20 ml) by cardiac

puncture 90 min. after IV injection and jmmediately transferred to
vacutainer tubes containing citrate at
stored frozen until analysis.

4~C.

Plasma was prepared and

Gunnison and Palmes showed that plasma

S-sulfonates were stable when stored at -l5°C for 46 days (7).

Plasma

aliquots of 1.0 ml were analysed for cysteine-S - sulfonate by the
described method as shown in Fig. l and for cyanolytic sulfite by the
Gunnison method .

Plasma aliquots were also analysed after dialysis

against 3- l liter changes of 0.9% NaCl-6 mM Tris buffer, pH 7 . 4 for
24 hours to determine the level of low molecular weight S- sulfonates.
The described method allowed us to analyse the dialysate for the
presence of cysteine- 5- sulfonate.
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TWO- STAGE ENZYMATIC HYDROLYSIS OF PROTEIN SAMPLE

t
SHORT COLUMN CATION-EXCHANGE CHROMATOGRAPHY OF DIGEST
TO SEPARATE CYSTEINE AND CYSTEINE- S- SULFONATE

t
t
t

SILYLATION OF COLUMN EFFLUENT

GLC OF DERIVATIVE

QUANTITATION OF CYSTEINE- S-SULFONATE

Figure 1.

Flow chart of the proposed method for quantitation of
cysteine-S-sulfonate in physiologically important proteins.

RESULTS

Method Development:

Research

The effectiveness of the proteolytic enzyme regimen employed for
the complete hydrolysis of sulfonated pr oteins was examined using
S-BSA.

Bovine serum albumin was chosen as a model for sulfonation

because it is a well characterized protein with 17 disulfide bridges

per molecule and offers a good substrate for sulfito l ysis.

In add-

ition, albumin represents nearly two- thirds, by weight, of the plasma

pro teins in humans and thus is the major protein that would be encountered in an anal ysis of human plasma.

Employment of the adaptation

of the Hill and Schmidt method for complete enzymatic hydrolysis of
proteins resulted in 95% hydrolysis of S-BSA (based on 154 umole amino
acids/20 mg S-BSA) as illustrated in Fig. 2.

Liberation of total amino

acids was followed with ninhydrin and confirmed using amino acid

analysis .

A burst of proteolytic activity was observed following the

addition of both pronase and the LAP-prolidase combination to the
hydro lysate.

The 24 hour hydrolysis period was convenient and achieved

sufficient hydrolysis of S- BSA to quantitatively liberate cys teinyl S- sulfonate residues.

As pres ented in Table 1 , 93% of the original

cysteine in bovine serum albumin was recovered as cysteine-S-sulfonate

fro m S-BSA.

The 0.57mole% cysteine found in the S- BSA hyd rosylate was

most likely exogenous amino acid contributed by the proteolytic enzyme
preparations as well as a small amount of cysteine that was not
sulfonated.

Enzymatic hyd rolysis of unreacted bov ine serum albumin is

also presented in Table 1 as both a comparison and as a check on the
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Enzymatic hydrolysis of S-BSA(20mg). Prona se (2mg), leucine amino peptidase (LAP , lmg ),
and prolid ase ( 2mg) we r e emplo yed at pH 8 · 8 . 5. Progress of the r eaction was
monitored s pect rophotome trically «ith ninhydrin a t 570nm (16).
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Table l.

Sulfur-containing Amino Acid Composition of S-BSA and BSA
Determined by GLC Analysis of Enzymatic Hydrol ysate

S-BSA
Amino Acid

Found
mole %

BSA

Theory
mole %

Found
mole %

Theory
mole %

Cysteine

0.57

0

6 . 00

6.18

Cysteine-S-sulfonate

5.75

6.18

0

0

0

0

0

0

0.70

0.71

0.70

0.71

Cysteic acid

Me thionine

spec ificity of the described analysis for cysteine-S-sulfonate.

As

would be expected, no sulfonated cysteine was found in the bovine
s erum albumin.

The cysteine and methionine values presented in Table 1

were determined by amino acid anal ys is of the total enzymatic hydrolysate on a Beckman Automa tic Analyzer using a Durrum single column
system .

Methionine was also determined by gas chromatography o f t he

total hydro l ysate.
Using synthetic standards of cysteine- S-sulfonate and cysteine,

derivatives were sought which woul d be amenable to gas chromatography.
The TFA-butyl ester derivatization was attempted but only a stable
derivative for cysteine was detected by GLC.

Silylation in dimethyl -

formamide produced stable trimethylsilyl (TMS) derivatives of both
cysteine and cysteine- S- sulfonate .
der iva tives are presented in Fig . 3.

Typical GLC chromatograms of the
As evidenced in these chromate-

grams, the retention times for both deriva tives were similar.
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GLC analysis of the TMS derivatives of synthetic standards
of cysteine- S- sulfonate(A) and cysteine (B) . Sample , column,
and condi tions are the same as Figure 4 .
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Calibration curves, shown in Fig . 4, illustrate a linear response with

a slope of 2 on a log-log plot for both the cys teine-S-sulfonate and
cysteine TMS derivatives which is characteristic of the sulfur - mode
flame photometric response (20) .

There was a 10- fold greater sensi-

tivity for the cysteine derivative over the cysteine-S- sulfonate
derivative.

The minimal detectable amount for cysteine- S-sulfonate was

6 nmoles wit h a peak height of lOmm.

In addition, the cysteine- S-

sulfonate 'D-IS derivative was more susceptible to degradation in air

than the cysteine TMS derivative.

This problem was overcome by the

use of teflon-lined septa which permitted the direct removal of the
derivative without opening the reaction vial.

Conditions for effective separation of cysteine-S-sulfonate and
cysteine TMS derivatives by gas chromatography could not be found, so
it proved necessary to separate these prior to gas chromatography.

Rapid separatio n of the two analogs was possible before silylat ion
using short column cation-exchange chromatography with an acidic

eluant.

This step of the procedure takes advantage of the low pKa of

the S- sulfonate moiety.

The elution profile of a run of synthetic

standard of cysteine- S- sulfonate on the short cation-exchange column
is shown in Fig. 5.

Cysteine was not eluted under these conditions, and

it did not interfer with the recovery of cysteine- S- sulfonate .

Al -

though cysteic acid did elute at this pH, its TMS derivative was separable from the cysteine- S-sulfonate derivative on the GLC .

Running

the S- BSA hydrolysate on this column resulted in the elution of only
cysteine- S-sulfonate as determined by gas chromatography; this
finding was confirmed by the absence of cysteic ac i d in the complete
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Figu r e 4.

Cal ibra tion curves for the tr imethylsilyl der ivatives of
cys teine and cysteine- 5- sulfonate. Column: Z. O% OV-101 on
Chromosorb W- HP, 1. 8m X 4mm I .D. glass. Sample: silylation
volume, SOul ; silylation concentration , l Onmole amino acid/ul
Tri- Sil in DMF. Fl ow rate: Nz, 86ml/mi n; Hz , 140ml/min;
air, 35ml/min; Oz, ZSml / min. Temperature: inlet, 240°C;
column, 140°C; flame Egotometr ic detec tor , 165°C.
Sensitivity: 64 X 10
a.f . s.
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Figure 5.

Elution profile of a synthetic standard of cysteine-·S·-

sulfonate(l.Oumole) dissolved in O.Sml O.lN HCl(eluant)
and chromatographed on a short column(l . Scm X S.Scm) of
Dowex 50-X4 resin.

The sample was washed in with 0.5ml of

the eluant followed by continuous flow of the eluant.
Fractions(0.5ml) were collected and assayed for the presence
of cysteine-S-sulfonate using ninhydrin (16) and gas
chromatography of the TMS derivative.

amino acid analysis [differentiation of cysteic acid and cysteine-S-

sulfonate was possible on the amino acid analyzer even though they
cochromatogr aph by using a comparison of the 570 nm/440 nm ratio as
empirical ly demons tra t ed by DeMarco
acids coeluted from the column .

et al, (11)].

No other amino

A typical GC chr omatogram of the TMS

derivatives of the S- BSA digest before and after the catior.-exchange
chromatography is pr esented in Fig. 6 (A) and 6 (B) respectively .

Method APplication:

Confirmation of Cysteine- S- sulfonate in Plasma
of Rabbits Treated With Sulfite.

To demonstrate the utility of the described method, cysteine-Ssulfonate was determined in plasma samples obtained from a sulfite-

treated rabbit .

The results, presented in Table 2, show that 158

nmoles of cysteine-S- sulfonate was fo rmed in a rabbit treated with

sulfite as hypothesized and indirectly demonstrated by Gunnison and
Benton (4).
Plasma samples were dialyzed against normal saline buffered wit h
Tris at pH 7.4 to determine the proportion of cysteine- S-sulfona t e

not

associated with plasma proteins.

As indicated in Table 2, 30%

of the cysteine- S-sulfonate was dialyzable and determined directly in
the dialyzate.

For comparison, Gunnison's spectrophotometric method

was run on plasma samples obtained from the same sulfite-treated
rabbit .

As shown in Table 2, the total S- sulfonate level was lower

than the S- sulfonate level determined as cysteine-S- sulfonate by the
proposed GC method .

The S-sulfonate levels generated by the spec -

trophotometric method was in very close agreement to values reported

17
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METHIONINE

CYS·S·SULFONATE

+
CYS

(B)
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RETENTION TIME (m;n)

Figure 6,

GLC analysis of enzymatic hydrolysate of S BSA before(A)
and after cation exchange chromatography(B). Injection
volume : 2ul(A) and Jul(B) . Column and conditions are the
same as Figure 4.
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by Gunnison and Palmes (6).

This indicates that the sulf ite-treatment

technique reproduced S-sulfonate levels previously generated by Gunnison
and Palmes; they reported 56% dialyzable low molecular weight S-sulfonate
as compared to 53% reported here.

Table 2.

Cysteine- S-sulfonate and total S-sulfonate levels in rabbit
pl asma following treatment with sulfite (0.7 mmole /kg BW) as
determined by the proposed GLC method and t he spectrophoto metric method of Gunnison (4).

GLC method
Cysteine-S-sulfonate

nmole/ml plasma
undialy zed
dialyzed
fraction dialyzed

Spectrophotometric
method
Total S- sulfonate
nmole/ml plasma

110

46

77

21

(30%)

(53%)

To as sess the efficiency of the spectrophotometric method for
de tecting cysteine-S-sulfonate residues as cyanolytic sulfite in
sulfonated protein, the method was applied to i ntact S- BSA and enzymatically hydrolysed S- BSA.

The data presented in Table 3 indicate that

about 37% of t he cysteinyl-S- sulfonate residues were not accessible
to alkaline cyanolysis prior to enzymatic hydrolysis .
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Table 3.

Total s-sulfonate levels of intact S-BSA and enzymatically
hydrolysed S-BSA as determined by the spectrophotometric
method of Gunnison (4).

Total S- sulfonate
fraction of theor etical
Intact S-B SA

60%

Enzyma ti cally hydrolysed
S-BSA

97%

a theoretical is based on amino a cid analysis of sulfonated bovine
serum albumin
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DISCUSSION
By use of the described method, which combines the selectivity of
cation-exchange chromatography and the sensitivity of the FPD-GLC,
cysteine-S-sulfonate was directly shown to occur in sulfonated bovine

serum albumin and rabbit plasma proteins following treatment with

sulfite.

Heretofore, the presence of cysteinyl-S-sulfonate residues

in plasma proteins of sulfite-treated mammals had been indirectly

demonstrated via sulfite displacement and radiolabeled sulfur experiments (3 ,4).

Confirmation of this sulfite adduct is important to

future attempts to monitor systemic exposure to sulfite.
An essential feature of the proposed method was the use of

enzymatic hydrolysis to insure the stability of the acid-labile S-sulfonate moiety.

As presented in Table 1, the enzymatic hydrolysis was

effective in quantitatively releasing the cysteine-S-sulfonate from

S-BSA.

It is interesting tha t the hydrolysis of S-BSA occured more

rapidly than the hydrolysis of bov ine serum albumin.

A possible ex-

planation is that sulfonation permits better access by the proteolytic

enzymes to the sites of hydrolysis by breaking disulfide bonds and
thus unfolding the albumin molecule.

While the described use of

proteolytic enzymes is costly and cumbersome fo r routine analytical

work, it is likely that this may be improved upon through the use of
matrix- bound proteinases (14) .
Quantitation of cysteine-S-sulfonate by gas chromatography with
the sulfur-specific detector offers increased sensitivity over conventional colorimetric detection methods .

The calibration curves shown

in Fig. 3 indicate that the gas chromatographic method was sensitive
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to a minimum of 6 nmole of cysteine- S-sulfonate with the optimum linear
range from 10-100 nmole.

Preliminary experiments indicate that the

potential for greater sensitivity by manipulation of the cysteinyl-Ssulfonate residues prior to derivatization is possible.

This would

utilize the acid lability of the S-sulfonate group, making it possible
to analyze cysteine-S-sulfonate as the cysteine derivative which

we showed had at least a 10-fold greater sensitivity.

Further work

is necessary to verify the accura cy and utility of such an alternative

for improving the sensitivity of this met hod.
The cysteine-S- sulfonate level in undialyzed rabbit plasma was
shown to be 2 . 4 times higher by the described GC method than the total
S- sulfonate determined by the spectroph0tometric method.

In searching

for an explanation to this discrepancy, the spectrophotometric method

was run on the model protein, S-BSA.

The data presented in Table 3

indicated that there were "buried" S-sulfonate groups uncovered by the

enzymatic hydrolysis and thus made available to cyanolytic attack.

This

finding, however, does not fully account for the 2-fold difference in
values.

The contribution of exogenous cysteine-S-sulfonate by the

protease preparations was ignored because no cyst eine-S-sulfonate was

detected in dialyzate s of the protease preparations.

Further applica-

tion of the two methods will have to be conducted to determine if this
discrepancy is statistically significant.

Thirty percent or 33 nmoles

of the total cysteine- S-sulfonate was detected by the GC method in the
dialyzate of the sulfite-treated plasma.

Since there is approximately

40 nmoles cystine/ml plasma in rabbits, it is most likely that this
cysteine-S-sulfonate was derived from free cystine that was sulfonated
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during treatment of the rabbit (6).

The level of low molecular weight

s - sulfonates found by the spectrophotometric method would be higher
because glutathione-S - sulfonate would also be.dialyzable.

The 30%

dialyzable sulfonate obtained with the GC method was determined by
direct analysis of the dialyzate and would be specific for cysteineS-sulfonate, therefo r e this value would be less than that determined
for the total low molecular weight S- sulfonates.
In conclusion, the data presented in Table 2 are significant in

that they confirm the presence of cysteine-S-sulfonate as a primar y
adduct formed upon treatment of rabbits with sulfite .

Previous attempts

to follow the distribution of bisulfite have lacked specificity for
the particular adducts formed when bisulfite is absorbed by the upper
airways or through the

G.I . tract, enters the circulatory system, and is

deposited in peripheral tissues (21,9).

This method allows investiga-

tors to selectively probe the distribution of bisulfite for physiologically significant molecular interactions.

It is hoped that by judicious

employment of basic research techniques such as the method proposed
herein, the primary toxic agent(s) associated with sulfur oxides will

be determined .
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General Review of Literature

on Sulfite Exposure and Cysteine-S-sulfonate Biochemistry

Exposure to oxides of sulfur
Man is exposed to the hydrate bisulfite principally through the
inhalation of the gaseous air pollutants, sulfur oxides, and by in-

gestion of sulfite used in the processing of food and beverages.
Atmospheric exposure

Sulfur oxid.:s (SOx) are a combination of two gases -- sulfur dioxide
(S0 2 ) and sulfur trioxide (S03) --and particulate sulfates (Rso ).
4

Most

of these pollutants are emitted as sulfur dioxide but are chemically
converted in the atmosphere to

so 3

and sulfates.

The major sources of

SOz emissions are the burning of sulfur containing f uels, primarily
coal and residual oil, and such industrial processing as ore smelting

and petroleum refining (22) .

The industrial processing produces 1/4

the SOx produced by burning fossil fuels (22).

However, these indus-

trial emissions are less consistant and thus more difficult to control

than the general combustion of fossil

fuels ~

are the heaviest in the Midwest and Northeast .

Fuel combustion emissions
Factors contributing

to this higher emission level are (22):
1.

greater urbanization and industrialization density

2.

less natural gas supplies and thus greater dependence on
coal and fuel oil
use of regionally available high sulfur coal and imported
fuel oil.

3.

The sulfur content of coals used as fuel determines the final
concentrations of sulfur oxides emitted at the exhaust stack.

Coals

mined in the eastern U.S. are primarily bituminous and of high sulfur
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content where as coal mined west o f the Mississippi River are sub-

tuminous and lignite types of low sulfur content (22).

Toge t her,

these conditions ment ioned have resulted in average annual concentra-

tions a t downtown sites of 364 ~ g/m3 fo r New York City, 232 ug/m3 for
Chicago, and l52ugfm3 for Jersey City (23).

When compared to Western

cities such as Denver with 26~g / m3 one gains an appreciation for contribution these conditions make to the SOx pollution seen in the urban

areas of the East .
L1 Tal>l~

Table 4.

The main

so 2

standards for the world are presented

4 ( 24 ).
Atmospheric standards presently in use

COUNTRY

STANDARD

197 4

80 ~ g /m 3 (mean, year ) , 365 ug/ m3 (h ighest da y in
year) 1300 ~ g/m3 (3 hour maximum)

USSR

50 ug/m 3 (24 hrs), 500 ug/m3 (20 min)

J SA

c973
150 ug/ m3 (highest mont h) , 300 ug/m3 (highest day
in month) 750 ug/ mJ (3 0 min )

Sweden

:965
\lest Germany
:9 74

140 ~ g/m3 (24 hrs), 400 ug/m3 (30 min)

Japan
:973

120 ug/m3 ( 24 hrs), 300 ~ g / m3 ( l hr)

Die·tary Exposure
We must consider another important source of sulfur oxides exposure to man.

Sulfites as food additives have been in common

f or

centuries with the earliest recorded use dating to Roman times where
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they treated wines with S02 (25).

Various forms of sulfite such as

sodium sulfite, bisulfite, metabisulfite, and

so 2

have been used to

prevent browning of light colored foods during the processing of dehydrated fruits and vegetables such as dried apples and instant
potatoes (26).

In addition one of the least known but none the less

major contributors of dietary sulfite is its use as a selective anti-

bacterial agent allowing yeast development during wine making (26, 27).
When these compounds are dissolved in HzO they dissociate into the .

sulfite, S0) 2

or oisulfite, HS03, as described by the fol~owing

equilibrium: (28)

-H+

-H+

so 2 + H 2 o~ H2 so 3 ~HSO) ;;;;=±so 3=
at pH 7.2, 25"C, and

low salt concentration, bisulfite and sulfite

will appear in equal concentration ( 28) .

In the presence of water and the organic constituents of foods or
beverages, the possibilities for their chemical reaction are numerous,

the three most common being oxidation to sulfate (29, 30) addition
across carbonyl groups (31, 32) and addioion to disulfide linkages in
proteins (33).
This type of reactivity of sulfite with other compounds makes it

difficult to determine the exact amount of sulfite ingested in the
"normal diet" of humans.

Gibson and Strong attempted to estimate the

average dietary intake of sulfite in the USA by basing their per capita
estimates on a population of 200 million with the beer and wine

drinking population 2stimaoed at 75% of the tctal.

Solid foods and

non-alcoholic beverages contributed approximately 2mg SOz/day to the
total, while alcoholic beverages accounted for the remainder (beer 1.2

29

an~

wine 3.0 mg S02/day).

Because of the inclusion of alcoholic

beverages, children are not included in these per capita estimates

presented in Table 5 (34).
Table 5.

Dietary sulfite levels.

Levels of intake

mg/kg*

mg/70 kg man*

US Average

0.10

US Maximum

1.7

120

FAO/WHO "acceptabl e"

0.35

25

FAO/WHO "conditionally acceptable"

1.5

105

*Expressed as

7.2

so 2

This estimate is in close agreement with an estimate by Bigwood for

the daily S02 consumption in Belgium.

The major difference is the

estimate for alcoholic beverages with Bigwood at 16.3 mg/day vs Gibson
at 5.2 mg/day (35).

Exposure estimate

By bringing these two routes of exposure together, one can calculate a maximum exposure level for oxides of sulfur in the U.S.
maximum concentration for S02 in the workplace is 4 .1 ppm.

The

If a worker

was exposed at this concentration for 8 hours of light work, he would

absorb 140 mg of

so 2 .

In addition if he were to consume the U.S. max

dietary sulfite level of 120 mg that would be a total of 260 mg of
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sulfite/day.

As one can see, this is a significant exposure to a

reactive chemical moiety for which the molecular targets have not

been fully elucidated.

MetaboliSl!l

Sulfite is rapidly absorbed into the blood of mammals either by
the nasotrachea region or by the digestive tract depending on the exposure (34, 36).

Once in the blood the sulfite has been shown to

react very rapidly with disulfide bonds of cystine, protein, and other
low molecular weight disulfide-containing molecules (37).

Using a

spectrophotometric color reaction that follows the uptake of inorganic
sulfite, Gunnison and Benton were able to follow the uptake of sulfite
by plasma proteins, cysteine, cystine, oxidized glutathione, and insulin.

They weren't able to identify the product species directly,

but offered evidence that it was the $-sulfonate of cysteine that was
being formed by the following reaction :
RSSR

+ SO~-~ RSSO_) +

This reaction is not without precedent.

RS-

It has been used as a gentle

method for breaking disulfide bonds in vitro and was suggested by many
workers as part of normal sulfur metabolism in molds and mammals (38-

42).
Expanding the use of their indirect method, Gunnison and coworkers
have accumulated a wealth of kinetic data on the absorbtion, distri-

bution, and elimination of both inhaled SOz and dietary sulfite (43-

31

46).

The evidence indicates that sulfite pharmacokinetics in mammals

fits a two-compartmental, open-system model when administered by rapid

i.v. injection.

It has been suggested that the sulfite rapidly dis-

tributes between a central compartment from which it is eliminated and

a peripheral compartment.

A graphic representation would look like

this:

central compartment

and described by the following equation :
C

p

= Ae-a t +Be- St

where Cp=plasma concentration, A,B=coefficients (nmole/ml) a, S ,=hybrid
rate constants.
Supporting evidence for a slower equilibrating peripheral com-

partment has recently been presented by Gunnison and Farrugella (47).
They demonstrated the formation of stable S-sulfonates in microfibril-

lar proteins of the lung and aorta of rabbits with clearance half lives
of 2-3 days.

Gibson and Strong also suggested that radio-labeled

sulfite not eliminated from rats might be bound to body components
with a slow turnover rate (34) .

Balchum

et al

were able to detect

35s in the airway tissues of a dog one week after the animal had been
exposed to 35 so 2 through a trac heal cannula (48) .
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The clearance of absorbed su l fite from the central compartment is

qui t e rapid with 70% of an absorbed dose appearing in the urine within
24 hour s (34) .

The elimination rate constants for i .v .-administered

sulfite have been determined in rabbits and rhesus monkey (4 5).
Gunnison and Palmes have shown that sulfite is cleared almost exclusively by oxidation to sulfate (45).

This oxidation of sulfite to

sulfate is catalyzed by t he enzyme sulfite oxidas e (sulfite:
oxidoreductase , EC 1.8.3.1 ) (49) .

02

This enzyme has been found in all

mammals investigated and in a variet y of tissues but primaril y i n the

liver and kidney ( 49).

The essential nature of this enzyme in humans

was observed in a two year old patient bo rn with an apparent deficiency

in this enzyme.
of age.

The child was highly abnormal and died at 2 1/2 years

The pa tient's metabolism was s uc h that it excreted inorganic

sulfi t e and 5-sul fonates but no sulfa te (50) .
Supporting evidence indicating the essent ial nature of sulfite
oxidase in protec t ing against su l fite exposure was perf ormed by Cohen

e t al. (51).

Sulfite oxidase is known to contain molybdenum.

Cohen

at a!. were able to pr oduce a sulfite oxidase deficient condi t ion by

feeding rats a low molybdenum diet ( 30

~g/kg

of diet) and allowing the

animals free access of water supplemented with 100 ppm tungsten .
Tungsten has been shown by Higgins et al . to be a competitive inhibitor
of Mo in animal systems (52) .

Animals treated with tungsten and low

Mo diet for 3 weeks and 5 weeks showed a Ln 50 to sodium bisulfite
(I.P. inj .) of 271 and 181 mg/kg , r esp ectively .

The LD50 fo r t hose

on rat chow was 551 mg/kg and those on low Mo wi thout tungsten, 475
mg /kg .

Animal exposed to SOz showed no difference in survival rate of

33
contr ol animals but did show difference in survival time.

the symptoms accompanying death were different.

In addition

Those animals defi-

cient in sulfite oxidase exhibited central nervous system disorders

while those on normal diet showed symptoms largely associated with
respiratory difficul ties.
It has been proposed that the suspected S- sulfonates formed by
the reaction of sul fite with disulfide bonds is a buffer system which
gives sulfite oxidase time to oxidize the sulfite to sulfate by binding
the sulfite and rende ring it inact i ve.

The following metabolic scheme

has been suggested (53):

1, occurs in blood and lung tissue

2-7, occur in liver
2 , NADPH+ dependent reduction
3 , reductive cleavage

4, catalysis by rhodanase or thiosulfate reductase
5, oxidation
6 , tissue metabolism

7 , catalysis by sulfite oxidase
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Reactions with Nucleic Acids
A review of the biochemical effects of sulfite would not be complete without a brief summary of the reaction of sulfite with nucleic
acids.
l)
2)
3)
4)

The principal reactions were reviewed by Shapiro (28):
deamination of cytosine
transamination; crosslinking of proteins
addition of bisulfite to uracil and thymine
free radical reactions.

The concern surrounding the interaction of sulfite Yith nucleic
acids is the increasing awareness of the correlation between mutagen-

esis and carcinogenesis (54) .

Since sulfite has been shown to cause

deamination of cytosine the potential for a mutant transition could

result in a new arrangement of bases during the replication process (55).
It is evidence of this nature that has heightened the concern over
systemic exposure to sulfite and raised the question of dietary tol er -

ances.

For a good review of the biochemistry of sulfite see Shapiro

and Petering (28 , 52).
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